Cyclacel Pharmaceuti (CYCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYCC | INVO | BDRX | ||
| Company | Cyclacel Pharmaceuti | Invo Bioscience Inc | Biodexa Pharmaceuticals Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3200 | 1.0300 | 1.1700 | ||
| High | 1.4500 | 1.0981 | 1.3300 | ||
| Low | 1.3000 | 1.0300 | 1.0800 | ||
| Last | 1.3600 | 1.0600 | 1.3100 | ||
| Change | -0.1500 | +0.0800 | +0.0100 | ||
| % Change | -9.93% | +8.16% | +0.77% | ||
| Volume | 1,499,300 | 315,500 | 3,100,100 | ||
| 20-Day Average Volume | 310,580 | 12,020,766 | 3,878,270 | ||
| Previous Close | 1.5100 | 0.9800 | 1.3000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8856 | 1.0383 | 0.9662 | ||
| 20-Day Raw Stochastic | 5.71% | 12.86% | 59.81% | ||
| 20-Day Relative Strength | 37.69% | 49.64% | 55.63% | ||
| Weighted Alpha | -86.15 | -86.64 | -91.16 | ||
| Today's Opinion | 100% Sell | 72% Sell | 64% Sell | ||
| Previous Opinion | 100% Sell | 88% Sell | 64% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -22.29% since 04/22/24 | -14.52% since 04/22/24 | +71.24% since 04/22/24 | ||
| Low | 1.3000 on 04/29/24 | 0.8901 on 04/25/24 | 0.6700 on 04/25/24 | ||
| High | 2.3499 on 04/24/24 | 1.4600 on 04/23/24 | 1.7400 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | -35.54% since 03/28/24 | -6.19% since 03/28/24 | -19.14% since 03/28/24 | ||
| Low | 1.3000 on 04/29/24 | 0.7000 on 04/16/24 | 0.6700 on 04/25/24 | ||
| High | 2.3499 on 04/24/24 | 3.5000 on 04/17/24 | 1.7400 on 04/26/24 | ||
| 3-Month | |||||
| %Chg | -40.35% since 01/29/24 | +0.95% since 01/29/24 | -32.82% since 01/29/24 | ||
| Low | 1.3000 on 04/29/24 | 0.7000 on 04/16/24 | 0.6700 on 04/25/24 | ||
| High | 3.0800 on 02/20/24 | 3.5000 on 04/17/24 | 2.1100 on 02/13/24 | ||
| 6-Month | |||||
| %Chg | -83.97% since 10/27/23 | -18.46% since 10/27/23 | -65.80% since 10/27/23 | ||
| Low | 1.3000 on 04/29/24 | 0.6300 on 11/09/23 | 0.6700 on 04/25/24 | ||
| High | 10.1220 on 11/06/23 | 3.5000 on 04/17/24 | 8.8100 on 11/27/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,991 | 2,688 | 1,673 | ||
| Shares Outstanding, K | 1,318 | 2,743 | 1,287 | ||
| Annual Sales | 420,000 | 3,020,000 | 860,000 | ||
| Annual Net Income | -22,560,000 | -8,030,000 | -9,470,000 | ||
| Last Quarter Sales | 30,000 | 1,380,000 | N/A | ||
| Last Quarter Net Income | -5,270,000 | -1,990,000 | N/A | ||
| 60-Month Beta | 0.54 | 1.45 | 1.49 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -6.23 on 03/19/24 | -0.70 on 11/13/23 | N/A | ||
| Latest Earnings Date | 05/09/24 | 05/20/24 | 04/26/24 | ||
| Most Recent Dividend | 0.150 on 07/13/16 | N/A | N/A | ||
| Next Ex-Dividends Date | 07/13/16 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||